Thermo Fisher Scientific Reports Third Quarter 2014 Results Third Quarter Highlights Grew adjusted earnings per share (EPS) by 32% to $1.71. Increased revenue by 31% to $4.17 billion. Expanded adjusted
Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement CARLSBAD, CALIFORNIA – Sept. 30, 2013 Life Technologies Corporation (NASDAQ: LIFE) and Advanced Cell Diagnostics, Inc. (ACD), a leader in
